Recent studies provide persuasive evidence that the majority of small renal masses will grow slowly over time and that these masses are associated with a low risk of metastatic progression.
As a result, researchers have advanced the idea that active surveillance may be an option for select patients, providing them with a way to avoid treatment-related morbidity such as surgical complications and decreased renal function.
Renal & Urology News would like to know what urologists think about this, so please answer the following poll question.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.